Excerpt

This short clinical guideline aims to improve the rehabilitation of adult general critical care patients. This includes recommending screening and/or assessment and appropriate rehabilitation strategies throughout the patient’s rehabilitation care pathway. Key principles of care and information and the support needs of patients and their families and/or carers are also addressed in this guideline. However, this guideline does not cover adult patients receiving palliative care, clinical subgroups of patients whose specialist rehabilitation needs are already routinely assessed and delivered as part of their care pathway (for example, patients who received critical care as part of an elective pathway and who did not develop an unanticipated, continuing critical illness), and in specialist areas where published guidelines already exist, such as head injury, myocardial infarction and stroke.

Contents

• Foreword
• Summary
  • 1.1. List of all recommendations
  • 1.3. Introduction
• 2. Evidence review and recommendations
  • 2.1. Screening and assessment tools
  • 2.2. Rehabilitation strategies/programmes
  • 2.3. Information and support needs
  • 2.4. Research recommendations
• 3. Glossary, abbreviations and references
  • 3.1. Glossary and abbreviations
  • 3.1.3 References
• 4. Methods
  • 4.1. Aim and scope of the guideline
  • 4.2. Development methods
• 5. Contributors
  • 5.1. The Guideline Development Group
  • 5.2. Declarations
• Appendices
  • 6.1 Appendix 1. Scope
  • 6.2 Appendix 2. Structured clinical questions
  • 6.3 Appendix 3. Search strategy
  • 6.4 Appendix 4. Review protocols and evidence tables
  • 6.5 Appendix 5. Health economic evidence tables
  • 6.6 Appendix 6. NICE Checklists

Five NICE guidelines have been included on the Bookshelf as part of a pilot project. All NICE guidance is available on the NICE website at www​.nice.org.uk

NICE clinical guidelines are recommendations about the treatment and care of people with specific diseases and conditions in the NHS in England and Wales.

This guidance represents the view of NICE, which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, and informed by the summary of product characteristics of any drugs they are considering.

Implementation of this guidance is the responsibility of local commissioners and/or providers. They are reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this guidance should be interpreted in a way which would be inconsistent with compliance with those duties.